Medicare Group Q.P.S.C Future Growth

Future criteria checks 1/6

Medicare Group Q.P.S.C is forecast to grow revenue at 4.6% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth	18.8%
Revenue growth rate	4.6%
Future return on equity	n/a
Analyst coverage	Low
Last updated	24 Oct 2024

Recent future growth updates

Recent updates

Medicare Group Q.P.S.C's (DSM:MCGS) Returns On Capital Tell Us There Is Reason To Feel Uneasy

May 26

Investors In Medicare Group Q.P.S.C. (DSM:MCGS) Should Consider This, First

Apr 08

Dividend Investors: Don't Be Too Quick To Buy Medicare Group Q.P.S.C. (DSM:MCGS) For Its Upcoming Dividend

Mar 18

Medicare Group Q.P.S.C.'s (DSM:MCGS) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

Mar 09

Be Wary Of Medicare Group Q.P.S.C (DSM:MCGS) And Its Returns On Capital

Feb 16

Should You Use Medicare Group Q.P.S.C's (DSM:MCGS) Statutory Earnings To Analyse It?

Jan 28

Can You Imagine How Medicare Group Q.P.S.C's (DSM:MCGS) Shareholders Feel About The 20% Share Price Increase?

Jan 05

How Does Medicare Group Q.P.S.C. (DSM:MCGS) Fare As A Dividend Stock?

Dec 15

Medicare Group Q.P.S.C.'s (DSM:MCGS) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Nov 29

Earnings and Revenue Growth Forecasts

DSM:MCGS - Analysts future estimates and past financials data (QAR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2027	596	N/A	N/A	N/A	1
12/31/2026	569	N/A	N/A	N/A	1
12/31/2025	543	N/A	N/A	N/A	1
12/31/2024	522	N/A	N/A	N/A	1
9/30/2024	513	77	36	107	N/A
6/30/2024	498	69	37	106	N/A
3/31/2024	488	67	25	93	N/A
12/31/2023	486	66	24	88	N/A
9/30/2023	483	82	77	112	N/A
6/30/2023	488	86	65	108	N/A
3/31/2023	498	81	81	114	N/A
12/31/2022	487	79	58	103	N/A
9/30/2022	488	82	29	88	N/A
6/30/2022	496	83	33	86	N/A
3/31/2022	477	74	21	86	N/A
12/31/2021	484	79	40	99	N/A
9/30/2021	485	89	41	109	N/A
6/30/2021	495	87	48	114	N/A
3/31/2021	471	87	51	101	N/A
12/31/2020	477	86	63	115	N/A
9/30/2020	482	84	76	126	N/A
6/30/2020	458	75	69	121	N/A
3/31/2020	493	79	65	126	N/A
12/31/2019	491	78	66	121	N/A
9/30/2019	483	88	85	135	N/A
6/30/2019	485	85	93	138	N/A
3/31/2019	485	84	106	141	N/A
12/31/2018	484	85	111	140	N/A
9/30/2018	488	84	116	148	N/A
6/30/2018	483	81	N/A	154	N/A
3/31/2018	480	83	N/A	192	N/A
12/31/2017	471	80	N/A	187	N/A
9/30/2017	471	66	N/A	165	N/A
6/30/2017	463	67	N/A	167	N/A
3/31/2017	469	69	N/A	190	N/A
12/31/2016	469	65	N/A	184	N/A
9/30/2016	498	87	N/A	175	N/A
6/30/2016	529	115	N/A	146	N/A
3/31/2016	562	145	N/A	N/A	N/A
12/31/2015	596	180	N/A	148	N/A
9/30/2015	594	196	N/A	N/A	N/A
6/30/2015	581	197	N/A	150	N/A
3/31/2015	561	197	N/A	N/A	N/A
12/31/2014	528	182	N/A	119	N/A
9/30/2014	486	149	N/A	N/A	N/A
6/30/2014	459	125	N/A	124	N/A
3/31/2014	435	99	N/A	120	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if MCGS's forecast earnings growth is above the savings rate (14.7%).

Earnings vs Market: Insufficient data to determine if MCGS's earnings are forecast to grow faster than the QA market

High Growth Earnings: Insufficient data to determine if MCGS's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: MCGS's revenue (4.6% per year) is forecast to grow faster than the QA market (4% per year).

High Growth Revenue: MCGS's revenue (4.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MCGS's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/02 10:51
End of Day Share Price	2024/12/31 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medicare Group Q.P.S.C. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Saugata Sarkar	QNB Financial Services
Mehmet Aksoy	QNB Financial Services

Medicare Group Q.P.S.C Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

Price target decreased by 9.6% to ر.ق5.52

Price target decreased by 9.0% to ر.ق5.52

Price target increased to ر.ق9.01

Recent updates

New major risk - Dividend sustainability

Now 23% overvalued after recent price rise

Medicare Group Q.P.S.C. Announces Board Changes

Now 20% overvalued after recent price rise

Now 22% overvalued after recent price rise

New major risk - Share price stability

Price target decreased by 9.6% to ر.ق5.52

Medicare Group Q.P.S.C. to Report First Half, 2024 Results on Jul 21, 2024

First quarter 2024 earnings released: EPS: ر.ق0.07 (vs ر.ق0.07 in 1Q 2023)

Medicare Group Q.P.S.C. to Report Q1, 2024 Results on Apr 24, 2024

Medicare Group Announces Formation of Board of Directors for Term 2024-2026

Dividend reduced to ر.ق0.22

Full year 2023 earnings released: EPS: ر.ق0.23 (vs ر.ق0.28 in FY 2022)

Medicare Group Q.P.S.C., Annual General Meeting, Mar 24, 2024

Price target decreased by 9.0% to ر.ق5.52

Now 21% overvalued

Medicare Group Q.P.S.C. to Report Fiscal Year 2023 Results on Feb 20, 2024

Investor sentiment improves as stock rises 20%

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: ر.ق0.074 (vs ر.ق0.078 in 3Q 2021)

Medicare Group Q.P.S.C. to Report Q3, 2022 Results on Oct 20, 2022

Second quarter 2022 earnings released

Medicare Group Q.P.S.C. to Report First Half, 2022 Results on Jul 19, 2022

First quarter 2022 earnings released: EPS: ر.ق0.06 (vs ر.ق0.08 in 1Q 2021)

Less than half of directors are independent

Third quarter 2021 earnings released: EPS ر.ق0.078 (vs ر.ق0.073 in 3Q 2020)

Second quarter 2021 earnings released: EPS ر.ق0.034 (vs ر.ق0.036 in 2Q 2020)

Medicare Group Q.P.S.C's (DSM:MCGS) Returns On Capital Tell Us There Is Reason To Feel Uneasy

Price target increased to ر.ق9.01

First quarter 2021 earnings released: EPS ر.ق0.08 (vs ر.ق0.07 in 1Q 2020)

Investors In Medicare Group Q.P.S.C. (DSM:MCGS) Should Consider This, First

Dividend Investors: Don't Be Too Quick To Buy Medicare Group Q.P.S.C. (DSM:MCGS) For Its Upcoming Dividend

Medicare Group Q.P.S.C.'s (DSM:MCGS) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

New 90-day high: ر.ق9.34

Medicare Group Q.P.S.C., Annual General Meeting, Mar 22, 2021

Full year 2020 earnings released: EPS ر.ق0.30 (vs ر.ق0.28 in FY 2019)

Revenue beats expectations

Be Wary Of Medicare Group Q.P.S.C (DSM:MCGS) And Its Returns On Capital

New 90-day low: ر.ق8.65

Medicare Group Q.P.S.C. to Report Fiscal Year 2020 Results on Feb 23, 2021

Should You Use Medicare Group Q.P.S.C's (DSM:MCGS) Statutory Earnings To Analyse It?

Can You Imagine How Medicare Group Q.P.S.C's (DSM:MCGS) Shareholders Feel About The 20% Share Price Increase?

How Does Medicare Group Q.P.S.C. (DSM:MCGS) Fare As A Dividend Stock?

Medicare Group Q.P.S.C.'s (DSM:MCGS) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Third quarter earnings released

Third-quarter earnings released: Revenue beats expectations

Medicare Group Q.P.S.C. to Report Q3, 2020 Results on Oct 20, 2020

New 90-day high: ر.ق8.36

New 90-day high - ر.ق7.65

New 90-day high - ر.ق7.51

New 90-day high - ر.ق7.44